ml). Her condition improved slowly, and she was discharged after three weeks. Four months after the initial episode, taking no medication, she was considered to be cured; laboratory results are shown in the Conversio7n: SI to traditionial uwits-Blood glucose: 1 mmol,l _ 18 mg/100 ml.
Blood urea nitrogen: 1 mmol,l 2-8 mg/100 ml. Creatinine: 1 .cmol/lv 11 3 ,ug/100 ml. Uric acid: 1 smol I 16 8 1cg/100 ml. Calcium: 1 mmol/I14 mg/100 ml. Phosphorus: 1 mmol 1 3-1 mg/100 ml. Magnesium: 1 rLmol/l 24 .cg/100 ml.
Lactate: 1 ,umol I 9 ,ug 100 ml. Anion gap: 1 mmol/l 00 mg/100 ml. Urinary uric acid: 1 mmol 24 h b 6 mg/24 h.
Biochemical analysis of the remaining tablets kept in the original cardboard box detected the presence of 4-epianhydrotetracycline and anhydrotetracycline in a proportion of 60°'; the maximum tolerated content of these compounds is less than 3 ,.
Comment
This patient showed all the main features of the Fanconi syndrome. The finding of degradation products in the tetracycline tablets provides strong evidence for their being the cause of this renal tubular dysfunction.
Severe metabolic acidosis was prominent. Renal tubular acidosis due to the Fanconi syndrome was undoubtedly partly responsible for this. 
Case report
A 43-year-old porter was found in a confused state at home after a week of flu-like symptoms. On admission to hospital he was feverish (38 8'C) and dehydrated with clinical evidence of left lower-lobe pneumonia. He was disorientated but there were no focal neurological deficits. All the deep reflexes were difficult to obtain, and the plantar responses were extensor. The white cell count was normal (8 2 x 109/1 (8200/mm3); 86 % neutrophils, 8 % lymphocytes) but the plasma urea concentration was 11-7 mmol/l (70 5 mg/100 ml) and the serum aspartate aminotransferase activity 260 IU/l.
Chest radiography confirmed extensive consolidation in the left lung.
Cerebrospinal fluid was normal (white cell count 2-0 x 106/1, protein concentration 0-4 g/l, glucose concentration 4-0 mmol/l (72-1 mg/100 ml)). Subsequently Legionella pneumophila infection was diagnosed on the basis of a fourfold rise in fluorescent antibody titre.
Bulbar weakness with dysarthria, dysphagia, and nasal regurgitation of fluid became apparent on the fifth hospital day. Thereafter, as the confusion lessened increasingly severe limb weakness became apparent. The patient complained of distal numbness in arms and legs together with tingling and pronounced unsteadiness on attempting to walk. By his third week in hospital the bulbar palsy had disappeared. Examination then showed bilateral facial weakness but otherwise normal cranial nerves. Symmetrical wasting of the small hand muscles was evident together with noticeable distal weakness in arms and legs. The arms showed tremor on posturing and mild ataxia with use. There was moderate ataxia of the legs tested in the lying position and a more pronounced disturbance of gait and stance. The deep reflexes had disappeared but the plantar responses remained extensor. Subjective perversion of sensation to touch was present below the mid-calf on each side, and position sense was impaired at the fingers and toes. Vibration sense was lost below the iliac crests.
Nerve-conduction studies showed absent sensory action potentials in the arms and moderate slowing of motor conduction (25 m/s in the median nerve). A further specimen of cerebrospinal fluid four weeks after admission showed a protein concentration of 0 6 g/l. During the next two months the patient's weakness and sensory signs gradually resolved, though the tendon reflexes remained absent and the plantar responses extensor.
Comment
Though there was evidence of disturbance of the central nervous system (mental disorientation and extensor plantar responses), the neurological signs that developed in this patient with legionnaires' disease indicated predominant peripheral nerve dysfunction. Cerebellar ataxia has been noted as a complication of legionnaires' disease,4 but our patient's weakness and sensory loss were the likely cause of his ataxia.
Acute polyneuropathy, commonly designated Guillain-Barre syndrome, is a well-recognised complication of many specific infective processes. A rising cerebrospinal fluid protein concentration reaching high values in four to six weeks is characteristic. Whether the inflammatory damage to peripheral nerves is caused by the infective agent and its toxins or by an immunological response triggered by them has long been debated. Much evidence supports an immunological cause for this condition, but it is not clear whether our patient's neuropathy was of this type or a specific feature of legionnaires' disease. Kennedy et al3 found neurophysiological evidence for an acute axonal neuropathy in five patients with legionnaires' disease, though clinical manifestations were evident in only a single case. Their findings and the small rise in cerebrospinal fluid protein concentration in our patient offer some support for a specific neuropathy accompanying legionnaires' disease.
We thank Dr Acute polymyopathy during total parenteral nutrition Total parenteral nutrition is often used as nutritional support'; deficiency states of various nutrients have been recognised in association with it. We report four cases of an acute myopathy associated with total parenteral nutrition that improved dramatically either when the nutrition was stopped or with intravenous lipid supplementation.
Case reports
Case 1-A 59-year-old woman with coeliac disease and previously treated oesophageal carcinoma was started on total parenteral nutrition. Weight gain was 6 kg in 34 days. A lipid supplement (Intralipid 10%, Vitrium) was initially part of the regimen but was stopped because of thrombophlebitis at infusion sites. The figure shows plasma creatine kinase activities (normal < 140 U/1) from the day after the last infusion. Aspartate aminotransferase activity rose transiently on day seven, but no associated increase in bilirubin concentration or alkaline phosphatase activity occurred. Parenteral nutrition was stopped on day 20 because of muscle pain, tenderness, swelling, and tachycardia. By day 21 muscle symptoms had abated and by day 22 creatine kinase activity was normal. The ratio of 5,8,1 1-eicosatrienoic acid to arachadonic acid in plasma lipids was 1-4 on day 20 (normal <0.4). Seven days after parenteral nutrition was stopped the ratio was 0 3, and after 14 days no 5,8,1 1-eicosatrienoic acid was detected.
Cases 2 and 3-Two further patients with similar symptoms and responses to total parenteral nutrition were seen; they did not receive lipid supplementation.
Case 4-A 54-year-old woman was started on total parenteral nutrition for small-bowel fistula after gastrectomy for carcinoma of the stomach and gained 7 kg in weight. On day 23 she complained of muscle weakness and plasma creatine kinase activity was raised (figure). By day 29 she had developed muscle pain and tenderness. On day 32 a lipid infusion (Intralipid 10 %, 500 ml) was started and total parenteral nutrition continued. Muscle pain immediately lessened and then disappeared. Creatine kinase activity during total parenteral nutrition in cases 1 and 4.
by gas-liquid chromatography after extraction and hydrolysis. Deficiency of essential fatty acids was diagnosed when the ratio of 5,8,11-eicosatrienoic acid to arachadonic acid was greater than 0-4.2
Comment
The acute myopathy in these patients was clearly related to parenteral nutrition. Stopping the regimen resulted in clinical and biochemical improvement within hours and complete resolution of the myopathy within days. Hepatomegaly was not detected clinically, and there was no biochemical evidence of hepatic dysfunction.
The cause of the myopathy was not established, though deficiency of essential fatty acids probably played a part. Characteristic chemical evidence for such a deficiency was detected. Though measurable amounts of 5,8,1 1-eicosatrienoic acid are expected after parenteral nutrition without lipid supplementation, a ratio of eicosatrienoic to arachadonic acid of the magnitude seen here indicates severe deficiency.3 Parenteral nutrition causes high circulating insulin concentrations, which suppress release of endogenous essential fatty acids from adipose tissue stores, resulting in a relative deficiency. Stopping parenteral nutrition thus allows release of these acids. The rapid clinical and biochemical response brought about by adding a lipid supplement to the regimen (case 4) is consistent with this hypothesis. Deficiencies of phosphate, vitamin E, and selenium have been associated with myopathies and muscle damage but were excluded in these cases.
No further cases of acute myopathy occurred after intravenous lipid supplementation was added on a regular basis to the nutritional support protocol. Whether a pure deficiency of essential fatty acids was the direct cause of this syndrome was not established. The lipid supplement may provide another as yet unidentified nutrient or, alternatively, essential fatty acids may reverse the abnormality without correcting the basic defect. Whatever the mechanism, lipid supplementation seems to prevent and reverse the muscular syndrome without the need to stop the nutritional support.
